CHLOROPROCAINE HCI
NESACAINE(R) -MPF (CHLOROPROCAINE HCI INJECTION, USP) 2% (400mg per 20mL) (20mg per mL) 20mL VIAL
Approved
Approval ID
9611d194-b6dd-93f4-e053-2a95a90a1816
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 28, 2024
Manufacturers
FDA
HF Acquisition Co LLC, DBA HealthFirst
DUNS: 045657305
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CHLOROPROCAINE HCI
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51662-1408
Application NumberNDA009435
Product Classification
M
Marketing Category
C73594
G
Generic Name
CHLOROPROCAINE HCI
Product Specifications
Route of AdministrationINFILTRATION, PERINEURAL, INTRACAUDAL, EPIDURAL
Effective DateJanuary 28, 2024
FDA Product Classification
INGREDIENTS (4)
CHLOROPROCAINE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: LT7Z1YW11H
Classification: ACTIB
SODIUM CHLORIDEInactive
Quantity: 4.7 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT